Real-time CBD & hemp news from 16+ industry sources. Updated every 2 hours.
Multistate cannabis company Ascend Wellness Holdings, Inc. (AWH) on Monday announced a reverse stock split vote as part of their uplisting plan to a major U.S. ...
Kenya’s High Court has rejected a bid by a Rastafarian group seeking to legalize cannabis use for religious purposes in the nation, the BBC reports. The Rastafa...
Idaho voters will not vote whether to legalize medical cannabis in November after advocates fell short of the required number of valid petition signatures. Idah...
Cannabis Client Alert – Week of July 13, 2026 Dentons
Virginia marijuana regulators have launched a new online form and tip line through which people can report suspected violations of the state s newly enacted law...
The Department of War (DOW) has issued a memo to senior Pentagon leadership making clear that marijuana use by military service members and civilian employees o...
The next frontier in anxiety care: Synthetic CBD arrives - CNBC TV18 LinkedIn
Hi do you people know a good cbd live resin vape brand thats available in Europe and doesn t tast like the worst fake ? Thanks in advance submitted by /u/Kroxit...
The next frontier in anxiety care? Synthetic CBD gets its world-first approval CNBC TV18
THC/CBD Combo Might Ease Agitation In Late-Stage Dementia U.S. News & World Report
HHS/VA psychedelics partnership; ID medical marijuana push fails; CA data: Local bans boost illicit market; Study: Cannabis-infused tea happiness Subscribe to r...
India gets world's first synthetic CBD oral drug for anxiety after CDSCO approval Deccan Herald
India approves world's first synthetic CBD oral solution for anxiety treatment Deccan Herald
Leiutis marks global milestone with CDSCO approval for Synthetic Cannabidiol Oral Solution for mild to moderate anxiety disorders Express Pharma
(Edit to add I’m 20, and it’s fully legal where I am! Not sure if that matters) - Hello, I’m looking to see if anyone else has this issue. I seem to get really ...
Leiutis Pharma announces CDSCO approval for global-first synthetic CBD therapy to cure mild to moderate anxiety disorders BioSpectrum India
Leiutis Pharma announces CDSCO approval for global-first synthetic CBD therapy to cure mild to moderate anxiety disorders BioSpectrum India
ASX Cannabis Stock Cronos (ASX:CAU): What’s Keeping CBD Off Pharmacy Shelves? Kalkine Media
Leiutis marks global milestone with CDSCO approval for Synthetic Cannabidiol Oral Solution for mild to moderate anxiety disorders Express Pharma
First-of-its-kind trial finds dementia agitation eased by cannabis combination McKnight's Long-Term Care News
Showing 361–380 of 1000 stories